RNAC R&D Expenses
Cartesian Therapeutics Inc · R&D Expenses
RNAC R&D Expenses
Latest reported$68.39Mperiod ending
RNAC R&D Expenses ($10.49M → $68.39M)
Annual R&D Expenses
High-resolution chart · PNG
RNAC r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 58,034,000 | |
| 45,105,000 | |
| 71,260,000 | |
| 72,377,000 | |
| 68,736,000 | |
| 54,505,000 | |
| 42,743,000 | |
| 47,687,000 | |
| 45,165,000 | |
| 29,702,000 | |
| 22,980,000 | |
| 10,486,000 |